This paper examines recent evidence and also reviews macroeconomic statistics related to the development of technology markets. It examines approaches to the valuation of patents and the policy initiatives undertaken by OECD countries to foster patent valuation and exploitation.
Publications on Harmonisation of Regulatory Oversight in Biotechnology
This paper examines the tax treatment of corporate expenditures on selected intellectual assets and develops an indicator of the relative generosity of tax systems in OECD countries to such investments.
English, , 849kb
The 2006 edition OECD Biotechnology Statistics includes data for 23 OECD countries and two observer countries, plus China (Shanghai), and takes a major step forward in improving the comparability of biotechnology indicators among countries.
English, , 436kb
This report documents the growing importance of intellectual assets for firms and the economy more generally and draws a number of implications for policy makers.
This paper provides an overview of innovative activities across a wide range of OECD member and non-member countries, based on internationally comparable patent indicators.
This joint OECD-Spanish government workshop on "Researcher Careers for the 21st Century" aimed to address key issues on researcher careers. A summary of the workshop is available here.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
Most OECD Member countries have a regulatory system for the products of modern biotechnology intended for release to the environment and for food/ feed use. This page includes links to portals of each member country which include relevant information.
This paper outlines factors that may affect the ability of researchers to access patented inventions for legitimate research purposes. It reviews evidence of access limitations and explores options for the formulation of research exemptions that balance research use and patent holders' rights.